GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 94.106
AS - Asia 57.138
EU - Europa 39.897
SA - Sud America 8.017
AF - Africa 1.291
OC - Oceania 154
Continente sconosciuto - Info sul continente non disponibili 74
Totale 200.677
Nazione #
US - Stati Uniti d'America 88.042
SG - Singapore 20.676
CN - Cina 11.075
IT - Italia 8.951
VN - Vietnam 8.556
HK - Hong Kong 8.235
RU - Federazione Russa 6.723
SE - Svezia 6.067
BR - Brasile 6.032
CA - Canada 5.254
DE - Germania 4.349
IE - Irlanda 3.807
UA - Ucraina 2.745
GB - Regno Unito 1.817
FR - Francia 1.786
BD - Bangladesh 1.756
IN - India 1.418
FI - Finlandia 1.042
KR - Corea 896
AR - Argentina 725
TR - Turchia 677
ID - Indonesia 637
IQ - Iraq 557
AT - Austria 507
MX - Messico 435
PK - Pakistan 398
ZA - Sudafrica 397
NL - Olanda 393
JP - Giappone 323
EC - Ecuador 317
ES - Italia 311
PL - Polonia 295
SA - Arabia Saudita 289
PH - Filippine 268
CO - Colombia 249
VE - Venezuela 212
DK - Danimarca 193
UZ - Uzbekistan 188
MY - Malesia 148
CL - Cile 134
MA - Marocco 134
PY - Paraguay 131
AU - Australia 127
TN - Tunisia 123
EG - Egitto 122
KE - Kenya 121
BE - Belgio 118
CZ - Repubblica Ceca 100
AE - Emirati Arabi Uniti 99
PE - Perù 89
TW - Taiwan 89
JO - Giordania 86
TH - Thailandia 83
ET - Etiopia 80
IR - Iran 73
NP - Nepal 72
JM - Giamaica 71
PT - Portogallo 71
RO - Romania 66
KZ - Kazakistan 64
CH - Svizzera 63
LT - Lituania 63
UY - Uruguay 60
AZ - Azerbaigian 59
GR - Grecia 58
DZ - Algeria 57
LB - Libano 54
BO - Bolivia 51
EU - Europa 50
PS - Palestinian Territory 49
BG - Bulgaria 47
AL - Albania 46
CR - Costa Rica 46
NG - Nigeria 45
DO - Repubblica Dominicana 42
OM - Oman 42
IL - Israele 41
SN - Senegal 40
HN - Honduras 34
HU - Ungheria 34
PA - Panama 34
TT - Trinidad e Tobago 34
KG - Kirghizistan 33
RS - Serbia 31
BY - Bielorussia 28
BH - Bahrain 27
NO - Norvegia 27
GT - Guatemala 23
SK - Slovacchia (Repubblica Slovacca) 23
SV - El Salvador 22
SY - Repubblica araba siriana 22
BA - Bosnia-Erzegovina 21
LK - Sri Lanka 21
LV - Lettonia 21
NI - Nicaragua 21
NZ - Nuova Zelanda 21
EE - Estonia 20
MU - Mauritius 20
CI - Costa d'Avorio 19
GE - Georgia 19
Totale 200.267
Città #
Ann Arbor 12.308
Singapore 10.806
Hong Kong 8.106
Ashburn 7.001
Fairfield 6.266
Woodbridge 6.104
Houston 4.637
San Jose 4.492
Toronto 4.142
Dublin 3.628
Chandler 3.318
Milan 2.986
Wilmington 2.890
Jacksonville 2.852
Seattle 2.624
Ho Chi Minh City 2.553
Frankfurt am Main 2.487
New York 2.349
Hanoi 2.049
Dearborn 2.034
Cambridge 2.015
Stockholm 1.960
Dallas 1.792
Chicago 1.751
Hefei 1.654
Princeton 1.650
Beijing 1.476
Santa Clara 1.447
The Dalles 1.403
Los Angeles 1.269
Lauterbourg 904
Rome 865
Seoul 833
Lawrence 779
Moscow 725
Altamura 724
Nanjing 704
Boardman 663
Buffalo 568
São Paulo 514
Shanghai 503
Council Bluffs 480
Lachine 460
Hangzhou 453
San Diego 435
Helsinki 397
Vienna 377
Jakarta 347
Da Nang 335
Guangzhou 334
Orem 303
Haiphong 281
Andover 277
Munich 277
London 250
Nanchang 244
Baghdad 239
Tokyo 215
Shenyang 210
Salt Lake City 193
Changsha 191
Hebei 191
Dong Ket 189
Rio de Janeiro 187
Atlanta 186
Ottawa 183
Tianjin 180
Warsaw 180
Nuremberg 165
Istanbul 160
Tashkent 160
Brooklyn 155
Chennai 153
Johannesburg 153
Turin 151
Montreal 149
Jiaxing 143
Figino 141
Jinan 141
Falls Church 137
Biên Hòa 131
Denver 131
Phoenix 131
Hải Dương 128
Columbus 127
Norwalk 126
Dhaka 124
Brasília 119
Can Tho 116
Lahore 115
Belo Horizonte 114
Lissone 113
Mumbai 113
Amsterdam 109
Fremont 108
Quito 108
San Francisco 108
Quận Bình Thạnh 107
Ninh Bình 105
Zhengzhou 105
Totale 129.571
Nome #
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 2.067
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 859
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 633
Dual renin-angiotensin systemblockade and vascular remodeling: Is this a real advantage for vascular protection? 622
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 601
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 542
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 540
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 488
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 487
Sex-related relationships between uric acid and target organ damage in hypertension 485
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 471
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 461
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 454
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 446
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 443
Heart rate as a sympathetic marker during acute adrenergic challenge 434
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 423
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 414
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 393
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 389
Early alterations in left ventricular diastolic function in normotensive diabetic patients 388
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 387
Persistence of arterial functional abnormalities after successful coronary revascularization 386
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 385
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 382
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 378
Calcium antagonists and neural control of circulation in essential hypertension 375
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 374
A case of Pseudomonas Aeruginosa commercial tattoo infection 369
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 365
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 365
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 365
Differing associations for sport versus occupational physical activity and cardiovascular risk 362
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 361
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 357
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 349
Statins and the risk of diabetes: Evidence from a large population-based cohort study 348
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 348
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 346
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 343
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 336
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 332
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 332
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 332
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 332
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 331
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 329
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 329
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 328
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 326
Cardiopulmonary receptor regulation of renin release 324
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 322
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 322
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 321
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 319
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 318
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 317
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 316
Historical Archive of Blood Pressure and Evolution of Hypertension 316
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 313
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 312
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 312
The Pamela study: main findings and perspectives 311
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 311
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 311
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 311
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 309
Heart rate as cardiovascular risk factor 309
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 309
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 308
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 307
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 307
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 306
Neurogenic abnormalities in masked hypertension 305
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 305
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 304
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 303
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 300
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 300
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 298
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 298
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 298
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 298
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 297
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 296
Modification of arterial baroreflexes by captopril in essential hypertension 296
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 295
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 294
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 294
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 293
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 293
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 293
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 292
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 292
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 292
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 290
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 289
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 288
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 287
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 287
Totale 37.480
Categoria #
all - tutte 675.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 675.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202680.996 8.086 5.966 5.890 7.638 7.574 3.917 9.810 3.526 5.925 8.153 7.167 7.344
2026/2027351 351 0 0 0 0 0 0 0 0 0 0 0
Totale 204.283